| Heading: |
Alzheimer's Disease: Medical Treatments |
| Question ID: |
1791257 |
| UIN: |
43291 |
| House: |
Commons |
| Date tabled: |
2025-04-01 |
| Asking Member ID: |
5255 |
| Asking Member display name: |
Joe Robertson
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Joe Robertson
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what discussions he has had with the National Institute for Health and Care Excellence on health technology assessment methods for evaluating novel therapies for Alzheimer's disease. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-04-09 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Department officials have regular discussions with the National Institute of Health and Care Excellence (NICE) about a range of topics, including its health technology assessment methods.The NICE develops its guidance independently on the basis of an asse... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |